Haegarda Available for Eligible Patients in Canada Starting April 6
News
Haegarda, CSL Behring’s preventive treatment for hereditary angioedema (HAE) attacks, will be available to eligible HAE patients across Canada starting on April 6. The availability announcement was issued by Canadian ... Read more